1. Home
  2. STRT vs CCCC Comparison

STRT vs CCCC Comparison

Compare STRT & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo STRATTEC SECURITY CORPORATION

STRT

STRATTEC SECURITY CORPORATION

HOLD

Current Price

$78.36

Market Cap

345.3M

ML Signal

HOLD

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$4.29

Market Cap

404.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STRT
CCCC
Founded
1908
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
345.3M
404.7M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
STRT
CCCC
Price
$78.36
$4.29
Analyst Decision
Hold
Strong Buy
Analyst Count
1
6
Target Price
$93.00
$12.20
AVG Volume (30 Days)
78.5K
3.4M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
12.53
16.45
EPS
4.04
N/A
Revenue
$439,195,000.00
$35,947,000.00
Revenue This Year
$4.22
N/A
Revenue Next Year
$2.04
N/A
P/E Ratio
$19.27
N/A
Revenue Growth
5.24
1.02
52 Week Low
$57.01
$1.44
52 Week High
$92.50
$5.17

Technical Indicators

Market Signals
Indicator
STRT
CCCC
Relative Strength Index (RSI) 47.87 57.67
Support Level $77.01 $2.10
Resistance Level $84.20 $4.60
Average True Range (ATR) 3.42 0.38
MACD -0.14 0.01
Stochastic Oscillator 9.83 44.41

Price Performance

Historical Comparison
STRT
CCCC

About STRT STRATTEC SECURITY CORPORATION

Strattec Security Corp designs develops, manufactures, and markets mechanical locks, electronically enhanced locks, and keys. It also produces ignition lock housings; and access control products, including latches, power sliding door systems, and door handles. Strattec ships products to customer locations in the United States, Canada, Mexico, Europe, South America, Korea, and China, and provides full-service aftermarket support. Strattec also supplies products for the heavy truck and recreational vehicle markets, as well as precision, die castings.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. The degrader medicines of the company are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT8919, and other discovery products.

Share on Social Networks: